Alimetry

Auckland, New Zealand Founded: 2019 • Age: 7 yrs
Non-invasive device for detecting gastric disorders is provided.
Annual revenue - Latest available
Total funding $29.0M 2 rounds
Employees - Tracked headcount
Investors 9 Known backers
Products 3 Services tracked
Competitors 8 Brand Intelligence

About Alimetry

Alimetry is a company based in Auckland (New Zealand) founded in 2019. Alimetry has raised $29.03 million across 2 funding rounds from investors including IP Group, Olympus America and Gastro. Alimetry offers products and services including Gastric Alimetry, Alimetry App, and Alimetry Report. Alimetry operates in a competitive market with competitors including Iterative Health, RNT Health Insights, Suzhou Huiwei Intelligent Medical Technology, Cosmo IMD and DigestAID, among others.

  • Headquarter Auckland, New Zealand
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Alimetry Limited
Operational Areas
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $29.03 M (USD)

    in 2 rounds

  • Latest Funding Round
    $18 M (USD), Series A

    Oct 29, 2024

  • Investors
    IP Group

    & 8 more

  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Alimetry

Alimetry offers a comprehensive portfolio of products and services, including Gastric Alimetry, Alimetry App, and Alimetry Report.

Product name locked
Category locked
Primary

System for mapping gastric electrophysiology to diagnose disorders.

Product name locked
Category locked
Locked

App for patients to log symptoms during gastric monitoring.

Product name locked
Category locked
Locked

Auto-generated report providing data insights for clinicians.

People of Alimetry

Headcount 10-50
Employee Profiles 14
Employee Profiles
People
Armen Gharibans
CTO
People
Chris Andrews
Chief Medical Officer
People
Stefan Calder
Chief Scientific Officer
People
Yaara Yarmut
Chief Regulatory Officer

Unlock access to complete

Funding Insights of Alimetry

Alimetry has successfully raised a total of $29.03M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $18 million completed in October 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Alimetry

Alimetry has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include IP Group, Olympus America and Gastro.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Venture capital funding is provided to high-growth global startups by GD1.
Locked Locked Locked
PE fund focused on high growth companies of New Zealand
Locked Locked Locked
Venture capital is provided to technology businesses by Movac.
Locked Locked Locked
Premium access

Investor details for Alimetry

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Alimetry

Investments
Premium access

Investment portfolio details for Alimetry

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Alimetry

Premium access

Detailed financials for Alimetry

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Alimetry Comparisons

Alimetry Primary company
Description
Non-invasive device for detecting gastric disorders is provi...
Location
Auckland, New Zealand
Founded Year
2019
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Alimetry

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Alimetry

Alimetry operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Iterative Health, RNT Health Insights, Suzhou Huiwei Intelligent Medical Technology, Cosmo IMD and DigestAID, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Provider of AI-based device for endoscopic images of gastroenterological diseases
Locked Locked Locked
Platform offering an AI assisted tool to aid endoscopists
Locked Locked Locked
AI-based diagnostic systems for digestive diseases are provided.
Locked Locked Locked
Develops AI software and hardware for intelligent medical devices in healthcare.
Locked Locked Locked
Develops AI technologies for detecting digestive lesions and endoscopy tools.
Premium access

Detailed competitors of Alimetry

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Alimetry

Premium access

Complete news archive for Alimetry

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Alimetry

Alimetry was founded in 2019 and raised its 1st funding round 3 years after it was founded.

Alimetry is headquartered in Auckland, New Zealand.

Alimetry is a funded company, having raised a total of $29.03M across 2 funding rounds to date.

Alimetry was founded in 2019 in Auckland, New Zealand, focusing on medical devices in the health technology sector. A non-invasive tool called Gastric Alimetry is offered, which is positioned on the patients skin above the stomach to monitor symptoms of upper gastrointestinal disorders. Operations center on device development and clinical applications for gastric condition assessment, with distribution targeted through healthcare channels.

Alimetry offers Gastric Alimetry, Alimetry App, and Alimetry Report.

Alimetry has 9 investors. Key investors include IP Group, Olympus America, Gastro, UniServices, and GD1.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available